BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  Genmab Leans into Hot ADC Space with $1.8B ProfoundBio Acquisition

  Genmab announced Wednesday it is buying ProfoundBio and its pipeline of next-generation antibody-drug conjugates being developed for gynecologic cancers and other solid tumors.

  April 3, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  FDA

  Vanda Gets FDA Approval for Fanapt Antipsychotic, Expands into Bipolar Disorder

  After sustaining a regulatory defeat in insomnia, Vanda Pharmaceuticals on Tuesday won the FDA’s approval for its atypical antipsychotic Fanapt for the treatment of manic or mixed episodes in adults with bipolar I disorder.

  April 3, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  FDA

  Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

  Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike.

  April 3, 2024

   · 

  6 min read

   · 

  Dimitrios Skaltsas, Bara Badwan, Panos Karelis
• 

  Policy

  Four Doses of Lilly’s Mounjaro Will Be in Short Supply Through April 2024: FDA

  The four highest doses of Eli Lilly’s blockbuster diabetes treatment Mounjaro will be in short supply through the rest of the month due to strong demand, according to the regulator.

  April 3, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Business

  Diagonal Therapeutics Nets $128M for New Approach to Agonist Antibodies

  The Cambridge-based biotech was co-founded by Atlas Ventures and CEO Alex Lugovsky to develop agonist antibodies for rare diseases, with a lead program in hereditary hemorrhagic telangiectasia.

  April 3, 2024

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Career Advice

  How to Manage Your Manager: Tips for Managing Up

  There are several ways you can maintain a good working relationship with your boss, starting with learning your manager’s work style, preferences and priorities.

  April 3, 2024

   · 

  3 min read

   · 

  Angela Gabriel
• 

  Opinion: The Next Generation of ADCs Will Improve Cancer Treatment

  Researchers are working to optimize the properties of antibody-drug conjugates in order to maximize clinical efficacy while minimizing the risk of toxicities.

  April 3, 2024

   · 

  5 min read

   · 

  Paul Moore
• 

  Job Trends

  The Top 11 Companies Hiring in Biopharma Now

  Looking for a biopharma job? Check out the BioSpace list of 11 top companies hiring life sciences professionals like you.

  April 3, 2024

   · 

  1 min read

   · 

  Angela Gabriel
• 

  Deals

  Acorda Joins Growing Group of Biotechs Filing for Bankruptcy, Divests Assets to Merz

  Acorda Therapeutics becomes the latest biotechnology company in 2024 to go bankrupt and shutter its business, following years of financial difficulty. Merz Therapeutics will acquire two commercial medicines from Acorda for $185 million.

  April 3, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Policy

  Biden, Sanders Target Drug Prices at White House Event

  Congress and the Biden administration have set their sights on lowering prescription drug costs.

  April 3, 2024

   · 

  2 min read

   · 

  Nadia Bey